Intent: Discussion and sharing of information relating to the geopolitical situation, specifically concerns surrounding the imposition of trade tariffs by the US. Understanding of the industry case for altering Ireland's position in the European Council relating to the GPL, as well as raising potential subjects for Ireland's EU Presidency agenda.
Details: IPHA Delegation to meet with An Tánaiste on EU health legislation and policy matters (including GPL and Ireland's EU Presidency), as well as the domestic issue of the negotiation of the pricing and supply agreement.
Intent: That the Government and MEPs must honour their commitments to stand up for farmers and defend their interests by opposing the current Mercosur trade deal.::To discuss farmers' concerns with the Minister for Foreign Affairs::To reiterate strong opposition to the Mercosur agreement in its current form. The beef industry in Ireland supports 90,000 farmers and around 25,000 jobs and is critical to the rural economy. There are very strong concerns about the impact the EU-Mercosur trade agreement would have on the viability of some 90,000 families.::That, while it is often argued that an additional 99,000t of beef from the Mercosur block countries would represent only 1-2% of the EU beef market, this statistic is in fact very misleading. The high value EU steak market (fillet, striploin, and cube) will be targeted by Mercosur beef exporters and will impact EU producers' ability to achieve a positive return on the carcass. 30% of the value of the carcass is contained within the yield of high
Intent: (a) Request to Irish Government to take account of the competitiveness of the pharmaceutical industry in Europe and not there dilute or reduce RDP. (b) Take account of the importance of the pharmaceutical industry in competitiveness of EU.
Details: (i) EU General Pharmaceutical Legislation and Irish Government position on Intellectual Property Rights. (ii) EU and Irish competitiveness and the pharmaceutical industry.
Intent: (i) The medicines reimbursement system should be designed and resourced to comply with the 2013 Health Act required for HSE decisions within 180 days excluding clock stops. (ii) Request for meeting to discuss IPHA proposals to address delays in the reimbursement system. (iii) Request to present IPHA Timeline data to the Oireachtas Health Committee.
Details: Future Framework Agreement - issues concerning timely reimbursement of medicines in Ireland.
Intent: (i) The medicines reimbursement system should be designed and resourced to comply with the 2013 Health Act required for HSE decisions within 180 days excluding clock stops. (ii) Request for meeting to discuss IPHA proposals to address delays in the reimbursement system. (iii) Request to present IPHA Timeline data to the Oireachtas Health Committee.
Details: Future Framework Agreement - issues concerning timely reimbursement of medicines in Ireland.
Intent: (i) Ireland to advocate for no tariffs on medicines from US, and in the event of such, no reciprocal tariffs by the EU on medicines. (ii) Response to US s.232 process should position Ireland as a reliable supply chain partner, part of 'friends and allies of the US' to avoid tariffs on medicines.
Intent: (i) Ireland to advocate for no tariffs on medicines from US, and in the event of such, no reciprocal tariffs by the EU on medicines. (ii) Response to US s.232 process should position Ireland as a reliable supply chain partner, part of 'friends and allies of the US' to avoid tariffs on medicines.
